ArticleThe oncologist2020

Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

James J Harding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.